and pelvic bones (18) . The clinical staging system for myeloma proposed by Durie and Salmon was adopted (12) .
SmolderingMultiple Myeloma . One patient (No. 14) fulfilled the criteria for smoldering myeloma (13) . At test this patient had been observed at the department for 4 yr. His condition had remained stable . However, 6 mo after test his condition deteriorated and treatment was instituted .
Chronic Lymphocytec Leukemia of B Cell Type (B-CLL). The main criteria for B-CLL was infiltration in bone marrow of small lymphocytes and >10 x 109/liter of lymphocytes in peripheral blood showing restriction for is or A light chains (19) . CLL patients were clinically staged according to the staging system of Rai et al. (7) . In this study a modification of the criteria for stage 0 was used to define a truly clinically benign condition : no general symptoms (fever, night sweat, weight loss), no enlarged lymph nodes, no hepatosplenomegaly, no anemia (Hb >120 g/liter), no thrombocytopenia (platelet counts >150 x 109/liter), and no increase in lactodehydrogenase (LD <8.0 ukat/liter) . Furthermore, during the observation period no significant increase in the blood lymphocyte count (doubling of the lymphocyte count) should have occurred. Moreover, no other symptoms or signs related to CLL should be present during the follow up (20) . The observation time for stage 0 B-CLL patients ranged from 47 to 192 mo.
Isolation of Lymphocytes
Mononuclear cells were isolated on Hypaque density medium . Adherent cells were removed by passage through nylon wool. T cells were isolated by panning of CD3' cells using OKT3 antibody. All T cell populations were >95% pure.
Probe
The cDNA probe for detecting the T cell clonality is a generous gift from Dr. Tak W. Mak (the Ontario Cancer Institute, Toronto, Ontario, Canada) . It is a 770-bp fragment that contains the J and C region of the human TCR S chain gene (20) , and was labeled using the commercial nick translation kit and [32 p]dCTP (Amersham International Ltd ., Amersham, UK).
Southern Blot Analysis
DNA was extracted with phenol and chloroform, and electrophoresed through 0.7% agarose gel after complete digestion with Eco RI and Barn HI (in some cases also with Hind III). Southern transfer and hybridizations were performed according to a standard protocol (21) . After hybridization, the filters were washed twice in 2 x SSC, 0.2% SDS at room temperature for 30 min and twice in 0.2 x SSC, 0.2% SDS at 65°C for 20 min. The autoradiograms were developed after the exposure at -70°C for 2-4 d.
Results
13 patients with B-CLL and 8 patients with MM were studied . Eight ofthe B-CLL patients were classified as stage 0 patients, a clinically benign condition with a good prognosis (7, 8, 10) . One of the MM cases was classified as a smoldering myeloma (13) at time of testing, but later required treatment (case 14).
T cells were isolated from patients by using anti-CD3 antibodies on solid phase. CD3 is a five-chain complex associated with TCR and a marker for mature T cells . DNA extracted from patient T cells was analyzed on Southern blots and compared with human germline, placental DNA . In four cases, evidence for T cell clonality was found (cases 1-3 and 14) (Table I ). In all these cases rearranged bands could be seen in the Barn I digestions. In DNA from patients 1, 2, and 4, rearranged bands can also be seen with Eco RI or Hind III digestions . This suggests rearrangements in either the COI or the C/32 gene, as both these can be detected in Barn HI diges- Case 1 showed two clones, both using Cß2 genes (Fig. 1) . Case 2 showed one rearranged band in the Bam HI digestion, indicating one dominant T cell clone using the Cß2 gene (Fig . 2) . Case 3 and 14 both had two rearranged bands in the Bam HI digest, but only one band in the Eco RI digestion, indicating rearrangements in the Cl locus (Figs. 3 and 4) .
Cases 1-3 were B-CLL patients in stage 0 and case 14 was a smoldering MM. Case 2. One rearranged band can be seen on the Bam HI blot . G, Germline DNA (from human placenta); T, DNA from T cells. No patients with a more advanced disease had signs of clonal T cell rearrangements, suggesting that the level of clonal T cells may be <5%.
Discussion
In 3 of 13 B-CLL patients and 1 of 8 myeloma patients evidence was found for a clonal predominance in the mature, peripheral T cell population . The method used was based on the detection of specific rearrangements within in the gene for the TCR,3 chain and has a sensitivity of 1-5% of the whole T cell population (22) . In other systems we have found that the development of detectable clones only occurs with defined antigens presented by autologous cells. Thus, a substantial part of the T cell population in the B-CLL and myeloma patients seems to be involved in recognition of certain restricted antigens, presumably expressed by the leukemic cells. In patients with rheumatoid arthritis, T cells derived from synovial membranes, and short-term tissue cultured in IL-2, have been found to contain a predominance of a limited number of clones by using the same technique as used in this report (23) . These cells may be reactive against autoantigens.
One potential class of antigens, which may be involved in B lymphoproliferative diseases, are idiotypes expressed by the tumor cell related surface Ig (3) (4) (5) (6) . However, at present, we have no information regarding the specificity of the clonal T cell populations, although in one case (No. 14), a short-term established T cell line could respond by DNA synthesis when challenged with purified idiotype protein and autologous antigen-presenting cells (data to be published) . However, it can not be excluded that the clones were reactive against nonleukemic antigens although no patients had any apparent infection at time of testing.
Clonal crosslineage rearrangements of the TCR fl chain can occur in B-type leukemias, more commonly in B-CLL, than MM (24) (25) (26) (27) (28) (29) (30) . However, we have several reasons to believe that the clonality we have detected was present in the T population rather than in monoclonal leukemic cells. First, mature T cells were isolated by solid phase separation with anti-CD3 antibodies. CD3 is a marker for mature T cells and only expressed by cells that express TCR at the cell surface. Second, in at least one case (No. 14), the patient had no malignant B cells in the peripheral circulation . Third, in three of the four cases with predominant clones, there was evidence for two clones . This strongly suggests that these are T cell derived as leukemic cells are clonal in nature (3). Fourth, in at least one patient with predominant clones, adherent leukemic cells that bound to nylon wool columns, were clearly negative for rearrangements of the TCR (3 chain gene (Fig . 3) .
All patients with clonal predominance in the T cell population were clinically benign cases, stage 0 B-CLL, or smoldering MM . This may indicate either that the reactive clones are involved in the control of the leukemic cells and/or that the T cell system is deregulated in more advanced cases. Some tumors are clearly immunogenic and an active human response may limit their growth (31) (32) (33) . In experimental B cell leukemias, isolated Ig idiotypes have been used to induce a humoral and cellular immune response against the corresponding leukemic cells (34, 35) . Campbell et al. (36) have synthesized peptides, corresponding to defined determinants binding to the TCR, and found that such peptides also could induce a similar effect .
The reasons why a clonal T cell predominance was only detected in 4 of 21 cases may be related either to a generalized T cell dysfunction or to properties of the leukemic cells. We and others have found a progressive T cell imbalance in later stages of B-CLL and myeloma, reflected by an inverted CD4/CD8 ratio and the appearance of suppressor T cells (3, 10, (12) (13) (14) . These suppressor cells may disturb a normal cellular immune response . In later stages the properties of the leukemic cells also change. One characteristic that may be important, and that we recently have studied, is the decreased capacity of more progressively growing B-CLL cells to secrete IL-1/3 (37) . Stage 0 B-CLL cells secrete normal levels of IL-1(3 in vitro and they also express cell surface markers typical for myelomonocytic cells (38) . Thus stage 0 B-CLL cells may be more active in antigen presentation, including processing of their own antigens than leukemias in more advanced stages .
In summary, in some cases of benign B-CLL and MM, there are predominant T cell clones present in the peripheral blood. Whether these clones are biologically and clinically important is presently unclear. To study this question, the clones need to be expanded in vitro, and characterized with regard to functional activity against tumor cells.
Summary
Clonality in the non-neoplastic T cell population was investigated in 21 patients with B cell chronic leukemic (B-CLL) or multiple myeloma (MM) by probing for TCR 0 chain gene rearrangements using Southern blot analysis . In three patients with a benign form of B-CLL (stage 0), and in one patient with smoldering MM, evidence was found for predominant T cell clones . As cellular immunity against the malignant cells may be important in leukemia, the results are discussed in view of the potential role of T cell immunity in B-CLL and MM .
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